{"id":"https://openalex.org/W4389986342","doi":"https://doi.org/10.1101/2023.12.19.572069","title":"Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids","display_name":"Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids","publication_year":2023,"publication_date":"2023-12-20","ids":{"openalex":"https://openalex.org/W4389986342","doi":"https://doi.org/10.1101/2023.12.19.572069"},"language":"en","primary_location":{"id":"doi:10.1101/2023.12.19.572069","doi":"https://doi.org/10.1101/2023.12.19.572069","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2023.12.19.572069","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2023/12/20/2023.12.19.572069.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2023/12/20/2023.12.19.572069.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034234418","display_name":"Shunqiang Li","orcid":"https://orcid.org/0000-0001-9508-7249","observed_orcids":["https://orcid.org/0000-0001-9508-7249"]},"institutions":[{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shunqiang Li","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Division of Oncology, Dept. of Medicine"],"raw_orcid":"https://orcid.org/0000-0001-9508-7249","affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008339153","display_name":"Tina M. Primeau","orcid":"https://orcid.org/0009-0005-8106-4798","observed_orcids":["https://orcid.org/0009-0005-8106-4798"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tina M. Primeau","raw_affiliation_strings":["Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047543960","display_name":"Maureen K. Highkin","orcid":"https://orcid.org/0009-0005-5923-7883","observed_orcids":["https://orcid.org/0009-0005-5923-7883"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maureen K. Highkin","raw_affiliation_strings":["Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076883802","display_name":"Stephanie L. Pratt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie L. Pratt","raw_affiliation_strings":["Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061005801","display_name":"Ashley R. Tipton","orcid":"https://orcid.org/0000-0003-0438-3726","observed_orcids":["https://orcid.org/0000-0003-0438-3726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashley R. Tipton","raw_affiliation_strings":["Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085644960","display_name":"Nagalaxmi Vemalapally","orcid":"https://orcid.org/0009-0001-1970-5460","observed_orcids":["https://orcid.org/0009-0001-1970-5460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nagalaxmi Vemalapally","raw_affiliation_strings":["Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013871009","display_name":"John D. Monsey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Monsey","raw_affiliation_strings":["Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039504311","display_name":"Yu Tao","orcid":"https://orcid.org/0000-0001-5087-7474","observed_orcids":["https://orcid.org/0000-0001-5087-7474"]},"institutions":[{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Tao","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Division of Biostatistics, Department of Surgery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Division of Biostatistics, Department of Surgery","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037696116","display_name":"Jingqin Rosy Luo","orcid":"https://orcid.org/0000-0003-2759-3072","observed_orcids":["https://orcid.org/0000-0003-2759-3072"]},"institutions":[{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingqin Luo","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Division of Biostatistics, Department of Surgery"],"raw_orcid":"https://orcid.org/0000-0003-2759-3072","affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Division of Biostatistics, Department of Surgery","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004313839","display_name":"Ian S. Hagemann","orcid":"https://orcid.org/0000-0002-3855-9745","observed_orcids":["https://orcid.org/0000-0002-3855-9745"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]},{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian S. Hagemann","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Department of Pathology & Immunology, all at Washington University School of Medicine, St. Louis, MO 63110"],"raw_orcid":"https://orcid.org/0000-0002-3855-9745","affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Department of Pathology & Immunology, all at Washington University School of Medicine, St. Louis, MO 63110","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040838377","display_name":"Chieh\u2010Yu Lin","orcid":"https://orcid.org/0000-0002-4269-3234","observed_orcids":["https://orcid.org/0000-0002-4269-3234"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]},{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chieh-Yu Lin","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Department of Pathology & Immunology, all at Washington University School of Medicine, St. Louis, MO 63110"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Department of Pathology & Immunology, all at Washington University School of Medicine, St. Louis, MO 63110","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086826368","display_name":"Lisa D. Eli","orcid":"https://orcid.org/0000-0003-3896-0966","observed_orcids":["https://orcid.org/0000-0003-3896-0966"]},"institutions":[{"id":"https://openalex.org/I4210154785","display_name":"Puma Biotechnology (United States)","ror":"https://ror.org/053kr4v45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210154785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa D. Eli","raw_affiliation_strings":["Translational Medicine and Diagnostics, Puma Biotechnology, Inc., 1880 Wilshire Blvd, Los Angeles, CA, 90024, USA"],"raw_orcid":"https://orcid.org/0000-0003-3896-0966","affiliations":[{"raw_affiliation_string":"Translational Medicine and Diagnostics, Puma Biotechnology, Inc., 1880 Wilshire Blvd, Los Angeles, CA, 90024, USA","institution_ids":["https://openalex.org/I4210154785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030565640","display_name":"Cynthia X. Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia X. Ma","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Division of Oncology, Dept. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001373717","display_name":"Ron Bose","orcid":"https://orcid.org/0000-0003-1977-8894","observed_orcids":["https://orcid.org/0000-0003-1977-8894"]},"institutions":[{"id":"https://openalex.org/I4390039355","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231","https://openalex.org/I4390039355"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ron Bose","raw_affiliation_strings":["Alvin J. Siteman Cancer Center","Division of Oncology, Dept. of Medicine"],"raw_orcid":"https://orcid.org/0000-0003-1977-8894","affiliations":[{"raw_affiliation_string":"Alvin J. Siteman Cancer Center","institution_ids":["https://openalex.org/I4390039355"]},{"raw_affiliation_string":"Division of Oncology, Dept. of Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5001373717"],"corresponding_institution_ids":["https://openalex.org/I4390039355"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neratinib","display_name":"neratinib","score":0.9789999723434448},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.9480000138282776},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9139999747276306},{"id":"https://openalex.org/keywords/breast-cancer-organoids","display_name":"breast cancer organoids","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pan-her-tyrosine-kinase-inhibitor","display_name":"pan-HER tyrosine kinase inhibitor","score":0.871999979019165},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.7639999985694885},{"id":"https://openalex.org/keywords/drug-combination-screening","display_name":"drug combination screening","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2779413316","wikidata":"https://www.wikidata.org/wiki/Q6995920","display_name":"Neratinib","level":5,"score":0.9378437995910645},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7630873918533325},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.7318605184555054},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6827468276023865},{"id":"https://openalex.org/C2778087150","wikidata":"https://www.wikidata.org/wiki/Q3997863","display_name":"Trastuzumab emtansine","level":5,"score":0.6590468883514404},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.5865334868431091},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5582199692726135},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5292127728462219},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5265833735466003},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5205984115600586},{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.4989285469055176},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4974720776081085},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42279481887817383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3729315400123596},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18270376324653625},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15791788697242737},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14930206537246704},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13217490911483765},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.09788140654563904},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.09507325291633606},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1101/2023.12.19.572069","doi":"https://doi.org/10.1101/2023.12.19.572069","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2023.12.19.572069","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2023/12/20/2023.12.19.572069.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1101/2023.12.19.572069","doi":"https://doi.org/10.1101/2023.12.19.572069","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2023.12.19.572069","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2023/12/20/2023.12.19.572069.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4119534169","display_name":null,"funder_award_id":"W81XWH","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G5459950798","display_name":"TARGETING HER2-ACTIVATING MUTATIONS IN ER-POSITIVE, METASTATIC BREAST CANCER","funder_award_id":"W81XWH1810084","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G5850682332","display_name":null,"funder_award_id":"W81XWH","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8166743225","display_name":null,"funder_award_id":"W81XWH-18","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G9000200483","display_name":null,"funder_award_id":"R01 CA161001","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320315130","display_name":"Alvin J. Siteman Cancer Center","ror":"https://ror.org/03jrmgg47"},{"id":"https://openalex.org/F4320318955","display_name":"Puma Biotechnology","ror":"https://ror.org/053kr4v45"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389986342.pdf","grobid_xml":"https://content.openalex.org/works/W4389986342.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1741548448","https://openalex.org/W1906450972","https://openalex.org/W1965157206","https://openalex.org/W1987576644","https://openalex.org/W2012939857","https://openalex.org/W2035484878","https://openalex.org/W2079012552","https://openalex.org/W2079244398","https://openalex.org/W2082592896","https://openalex.org/W2085470185","https://openalex.org/W2086811477","https://openalex.org/W2093208620","https://openalex.org/W2095659509","https://openalex.org/W2098775844","https://openalex.org/W2100230735","https://openalex.org/W2108244538","https://openalex.org/W2111912642","https://openalex.org/W2118952409","https://openalex.org/W2124358769","https://openalex.org/W2144124503","https://openalex.org/W2147060536","https://openalex.org/W2153072711","https://openalex.org/W2155794195","https://openalex.org/W2176258826","https://openalex.org/W2344726805","https://openalex.org/W2510203476","https://openalex.org/W2517720969","https://openalex.org/W2518696212","https://openalex.org/W2564066883","https://openalex.org/W2574695762","https://openalex.org/W2590503268","https://openalex.org/W2592465655","https://openalex.org/W2726739357","https://openalex.org/W2773981699","https://openalex.org/W2785610956","https://openalex.org/W2801652358","https://openalex.org/W2885650843","https://openalex.org/W2903143832","https://openalex.org/W2905447079","https://openalex.org/W2913284684","https://openalex.org/W2917438927","https://openalex.org/W2948402706","https://openalex.org/W2951222857","https://openalex.org/W2969544875","https://openalex.org/W2993603600","https://openalex.org/W3013150216","https://openalex.org/W4206007549","https://openalex.org/W4206348218","https://openalex.org/W4301159569"],"related_works":["https://openalex.org/W2984731942","https://openalex.org/W1964808503","https://openalex.org/W2944399106","https://openalex.org/W2947545363","https://openalex.org/W2785383873","https://openalex.org/W2767034692","https://openalex.org/W2762859595","https://openalex.org/W2405259065","https://openalex.org/W2985724618","https://openalex.org/W3164150197"],"abstract_inverted_index":{"Abstract":[0],"HER2":[1,28,35,38,70,83],"(":[2],"ERBB2":[3],")":[4],"is":[5,182],"a":[6,64,151],"major":[7],"therapeutic":[8],"drug":[9,93,115,122,174,180],"target":[10],"in":[11,31,42,142],"breast":[12,32,46,76,101],"cancer":[13,47,77,102,156,173,187],"and":[14,23,50,87,131,136,158],"The":[15],"Cancer":[16,21],"Genome":[17],"Atlas":[18],"(TCGA)":[19],"Breast":[20],"project":[22],"other":[24],"studies":[25],"have":[26,53],"identified":[27,121],"activating":[29,39],"mutations":[30,40,190],"cancers":[33],"without":[34],"gene":[36],"amplification.":[37],"occur":[41],"2-5%":[43],"of":[44,98,147,154,161,178],"metastatic":[45],"patients":[48,86],"(MBC),":[49],"clinical":[51,66,199],"trials":[52,200],"shown":[54],"that":[55],"the":[56,125,193],"irreversible":[57],"pan-HER":[58],"tyrosine":[59],"kinase":[60],"inhibitor,":[61],"neratinib,":[62],"produces":[63],"31-40%":[65],"benefit":[67],"rate":[68],"for":[69,185,198],"mutated":[71,84],"MBC":[72,85],"patients.":[73],"We":[74],"developed":[75],"patient-derived":[78],"xenografts":[79],"(PDX)":[80],"from":[81],"ER+,":[82],"used":[88],"them":[89],"to":[90,112,191],"test":[91,113],"neratinib-based":[92],"combinations.":[94,116],"Using":[95],"organoid":[96,118],"culture":[97,119],"these":[99,139],"PDX":[100,144,166],"cells,":[103],"we":[104,137],"performed":[105],"rapid,":[106],"high-throughput":[107],"ex":[108],"vivo":[109,143],"screening":[110],"assays":[111],"novel":[114],"These":[117],"experiments":[120],"synergy":[123],"with":[124,141,159],"neratinib":[126,132],"plus":[127,133],"ado-trastuzumab":[128],"emtansine":[129],"(T-DM1)":[130],"vinorelbine":[134],"combinations":[135],"validated":[138],"results":[140],"experiments.":[145],"Statement":[146],"Significance":[148],"PDX\u2019s":[149,162],"are":[150],"ready":[152],"source":[153],"human":[155],"organoids,":[157],"thousands":[160],"already":[163],"available":[164],"worldwide,":[165],"derived":[167],"organoids":[168],"(PDxO\u2019s)":[169],"can":[170],"dramatically":[171],"accelerate":[172],"testing.":[175,201],"This":[176],"strategy":[177],"PDxO":[179],"testing":[181],"particularly":[183],"useful":[184],"rare":[186],"subtypes":[188],"or":[189],"identify":[192],"most":[194],"promising":[195],"treatment":[196],"strategies":[197]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}